Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Products containing undeclared prescription drugs removed from Burnaby West Box store
- Starting date:
- February 3, 2014
- Posting date:
- February 3, 2014
- Type of communication:
- Source of recall:
- Health Canada
- Undeclared Substance, Unauthorized products
- General Public
- Identification number:
- Report health or safety concerns
- Related AWRs
- Media enquiries
- Public enquiries
Health Canada has removed unauthorized health products (see table below) containing various prescription drugs that should only be used under medical supervision, from the retail store, West Box in Burnaby B.C. These products may pose serious risks to the health of Canadians.
Health Canada has not received any adverse reactions reports associated with the use of these products.
Who is affected:
Canadians who either have used or purchased these products. These unauthorized health products were either being promoted for weight loss or for certain eye problems.
What consumers should do:
- Read the label of the products you buy to verify that they have been assessed by Health Canada for safety, effectiveness and quality. Health products that have been authorized for sale by Health Canada will have an eight-digit Drug Identification Number (DIN), a Homeopathic Medicine Number (DIN-HM) or a Natural Product Number (NPN) on the label.
- Report any adverse events using these products to Health Canada.
- Speak to your healthcare practitioner with any questions or concerns regarding these products.
What Health Canada is doing:
Through compliance verification activities, Health Canada identified that West Box (Unit 1337-4500 Kingsway, Crystal Mall) in Burnaby, B.C., was selling these unauthorized products, which were either being promoted for weight loss or for certain eye problems.
The prescription ingredients contained in the various "Crane" products were identified through testing at a Departmental lab.
|Product Name||Prescription Ingredient(s)||Indicated Use||Date Added|
|Crane Beauty Green Algae Compound Tablets||Sibutramine and sildenafil analog||Weight Loss||February 3, 2014|
|Crane Beauty Green Algae Body Slimming Combination||Fluoxetine||Weight Loss||February 3, 2014|
|Crane Beauty Green Algae Complex Tablets||Fluoxetine||Weight Loss||February 3, 2014|
|Crane Beauty Green Algae Perfect Match||Nicotine||Weight Loss||February 3, 2014|
|Santé FX Neo||Neostigmine methylsulfate||Eye drops for tired and red eyes||February 3, 2014|
|Santé FX V+||Neostigmine methylsulfate||Eye drops for tired and red eyes||February 3, 2014|
Products containing sildenafil should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardiovascular side effects if they engage in sexual activity, including if they use sildenafil. Other possible side-effects of using sildenafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
Sibutramine was previously used to treat obesity but is no longer authorized for sale in Canada because of its association with an increased risk of cardiovascular side-effects such as heart attack and stroke. In addition to heart attack and stroke, side-effects associated with sibutramine include increased blood pressure and heart rate, dry mouth, difficulty sleeping and constipation.
Fluoxetine is used to treat depression, bulimia nervosa, or obsessive compulsive disorder. Fluoxetine should never be used in combination with certain antidepressants or antipsychotic drugs, as this may lead to fatal side-effects. Fluoxetine may lead to changes in behavior and feelings, including thoughts about suicide and hurting others, changes in heart rhythms or birth defects and may cause allergic reactions.
Neostigmine methylsulfate is usually given as an injection by healthcare professionals to prevent and treat bladder and intestinal problems associated with surgery, to treat myasthenia gravis (a neuromuscular disease characterized by varying degrees of weakness), and to reverse the effect of certain anaesthetics. Neostigmine, when given by injection, has been associated with bradycardia (slow heart beat) and should therefore be administered with other drugs that would counteract this side-effect. It should be used only carefully in patients with coronary artery disease, or other heart problems.
Nicotine should not be used by pregnant women. Symptoms of a nicotine overdose include nausea, abdominal pain, vomiting, diarrhea, cold sweat, dizziness, disturbed hearing and vision, mental confusion, rapid heartbeat, difficulty breathing and marked weakness.
Report health or safety concerns
- Call toll-free at 1-866-234-2345
- Visit MedEffect Canada's web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Select thumbnail to enlarge - opens in a new window
For more information
Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.
Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.
- Date modified: